• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理T1b期结直肠癌淋巴结转移的危险因素

Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer.

作者信息

Naito Atsushi, Iwamoto Kazuya, Ohtsuka Masahisa, Imasato Mitsunobu, Nakahara Yujiro, Mikamori Manabu, Furukawa Kenta, Moon Jeongho, Asaoka Tadafumi, Kishi Kentaro, Akamatsu Hiroki

机构信息

Department of Surgery, Osaka Police Hospital, Osaka, Japan

Department of Surgery, Osaka Police Hospital, Osaka, Japan.

出版信息

In Vivo. 2021 Mar-Apr;35(2):987-991. doi: 10.21873/invivo.12341.

DOI:10.21873/invivo.12341
PMID:33622893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8045107/
Abstract

BACKGROUND/AIM: The rate of lymph node metastasis (LNM) of colorectal carcinoma (CRC) with a submucosal (SM) invasion depth of 1000 µm or more can reach 12.5%, which is the most common reason for additional resection in daily practice. Other studies have reported that the rate of LNM is less than 2%, regardless of the depth of invasion, if the lesions show good histology, lymphovascular infiltration is negative, and tumor budding is limited. The purpose of this study was to investigate new risk factors for LNM in T1b colorectal cancer.

PATIENTS AND METHODS

The 239 patients who were diagnosed with pathological T1b CRC after colorectal surgical resection at the Osaka Police Hospital in Japan between January 2008 and December 2018 were retrospectively reviewed in this study.

RESULTS

The LNM rate was 11.3% (27/239). The variables identified as being significant factors using multivariate analysis were: i) lymphatic invasion (Ly)-positive [odds ratio (OR)=5.97; 95% confidence interval (CI)=2.27-15.74], ii) female gender (OR=3.49; 95%CI=1.38-8.85), and iii) left-sided colorectal involvement (OR=4.98; 95%CI=1.22-20.39). If none of these risk factors were present with T1b, the LNM rate was 0% (0/28).

CONCLUSIONS

Ly-positive, female gender, and left-sided colorectal involvement could be risk factors for LNM in T1b CRC.

摘要

背景/目的:黏膜下(SM)浸润深度达1000µm或更深的结直肠癌(CRC)的淋巴结转移(LNM)率可达12.5%,这是日常实践中进行额外切除的最常见原因。其他研究报告称,如果病变组织学表现良好、无淋巴管浸润且肿瘤芽生有限,则无论浸润深度如何,LNM率均低于2%。本研究的目的是调查T1b期结直肠癌LNM的新危险因素。

患者与方法

本研究回顾性分析了2008年1月至2018年12月期间在日本大阪警察医院接受结直肠手术切除后被诊断为病理T1b期CRC的239例患者。

结果

LNM率为11.3%(27/239)。多因素分析确定为显著因素的变量有:i)淋巴管浸润(Ly)阳性[比值比(OR)=5.97;95%置信区间(CI)=2.27 - 15.74],ii)女性(OR=3.49;95%CI=1.38 - 8.85),以及iii)左半结肠受累(OR=4.98;95%CI=1.22 - 20.39)。如果T1b期不存在这些危险因素,则LNM率为0%(0/28)。

结论

Ly阳性、女性以及左半结肠受累可能是T1b期CRC发生LNM的危险因素。

相似文献

1
Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer.病理T1b期结直肠癌淋巴结转移的危险因素
In Vivo. 2021 Mar-Apr;35(2):987-991. doi: 10.21873/invivo.12341.
2
Lymph node metastasis in T1 colorectal cancer with the only high-risk histology of submucosal invasion depth ≥ 1000 μm.黏膜下浸润深度≥1000μm的 T1 结直肠癌中仅有高风险组织学的淋巴结转移。
Int J Colorectal Dis. 2022 Nov;37(11):2387-2395. doi: 10.1007/s00384-022-04269-6. Epub 2022 Oct 25.
3
Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.T1 结直肠肿瘤淋巴结转移的病理危险因素和预测性内镜因素:一项 846 例病变的单中心研究。
J Gastroenterol. 2019 Aug;54(8):708-717. doi: 10.1007/s00535-019-01564-y. Epub 2019 Feb 27.
4
Risk factors for lymph node metastasis in T2 colorectal cancer: a systematic review and meta-analysis.T2 期结直肠癌淋巴结转移的危险因素:系统评价和荟萃分析。
Int J Clin Oncol. 2024 Jul;29(7):921-931. doi: 10.1007/s10147-024-02547-7. Epub 2024 May 6.
5
Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis.深度黏膜下浸润不是 T1 结直肠癌淋巴结转移的独立危险因素:一项荟萃分析。
Gastroenterology. 2022 Jul;163(1):174-189. doi: 10.1053/j.gastro.2022.04.010. Epub 2022 Apr 15.
6
Predictors for lymph node metastasis in T1 colorectal cancer.T1 结直肠癌淋巴结转移的预测因素。
Endoscopy. 2012 Jun;44(6):590-5. doi: 10.1055/s-0031-1291665. Epub 2012 May 25.
7
[Lymph node metastasis and prognostic factors for T1 esophageal cancer].[T1期食管癌的淋巴结转移及预后因素]
Zhonghua Wai Ke Za Zhi. 2017 Sep 1;55(9):690-695. doi: 10.3760/cma.j.issn.0529-5815.2017.09.010.
8
A new clinical model for predicting lymph node metastasis in T1 colorectal cancer.一种用于预测 T1 结直肠癌淋巴结转移的新临床模型。
Int J Colorectal Dis. 2024 Apr 3;39(1):46. doi: 10.1007/s00384-024-04621-y.
9
Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma.黏膜下浸润性结直肠癌淋巴结转移的新预测因子。
World J Gastroenterol. 2017 Aug 28;23(32):5936-5944. doi: 10.3748/wjg.v23.i32.5936.
10
Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.早期胃癌内镜治疗的可行性及淋巴结转移的预测因素。
World J Gastroenterol. 2019 Sep 21;25(35):5344-5355. doi: 10.3748/wjg.v25.i35.5344.

引用本文的文献

1
Therapeutic efficacy of 5-alkylresorcinol on progression of colorectal cancer by activating HCLS1 and suppressing TLR4/MYD88/NF-κB signaling.5-烷基间苯二酚通过激活HCLS1和抑制TLR4/MYD88/NF-κB信号通路对结直肠癌进展的治疗效果
Eur J Med Res. 2025 Jun 18;30(1):487. doi: 10.1186/s40001-025-02775-1.
2
Comparative prediction of lymph node metastasis in pT1 colorectal cancer among Western and Japanese guidelines.西方和日本指南中pT1期结直肠癌淋巴结转移的比较预测
Front Oncol. 2024 Oct 31;14:1475270. doi: 10.3389/fonc.2024.1475270. eCollection 2024.
3
Vertical margin distance in T1 colorectal carcinoma resected by endoscopic submucosal dissection affects prognosis after additional surgery.内镜黏膜下剥离术切除的 T1 结直肠癌垂直切缘距离影响追加手术后的预后。
Int J Colorectal Dis. 2024 Aug 16;39(1):134. doi: 10.1007/s00384-024-04700-0.
4
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer.建立并验证一个列线图模型以预测结直肠癌肿瘤 deposits。
World J Gastroenterol. 2023 Oct 21;29(39):5483-5493. doi: 10.3748/wjg.v29.i39.5483.
5
Additional staining for lymphovascular invasion is associated with increased estimation of lymph node metastasis in patients with T1 colorectal cancer: Systematic review and meta-analysis.额外的淋巴管侵犯染色与 T1 结直肠癌患者淋巴结转移估计增加相关:系统评价和荟萃分析。
Dig Endosc. 2024 May;36(5):533-545. doi: 10.1111/den.14691. Epub 2023 Oct 25.
6
Endoscopic intermuscular dissection with intermuscular tunneling for local resection of rectal cancer with deep submucosal invasion.内镜下肌间剥离联合肌间隧道技术用于局部切除伴有深层黏膜下浸润的直肠癌。
VideoGIE. 2022 Apr 17;7(8):273-277. doi: 10.1016/j.vgie.2022.02.012. eCollection 2022 Aug.
7
Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.肿瘤芽作为 II 期结肠癌患者复发和生存的预测标志物。
In Vivo. 2022 Jul-Aug;36(4):1820-1828. doi: 10.21873/invivo.12898.

本文引用的文献

1
Endoscopic resection of T1 colorectal cancer prior to surgery does not affect surgical adverse events and recurrence.术前内镜切除 T1 结直肠肿瘤不影响手术不良事件和复发。
Surg Endosc. 2020 Nov;34(11):5006-5016. doi: 10.1007/s00464-019-07295-8. Epub 2019 Dec 9.
2
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2019 年结直肠癌治疗指南。
Int J Clin Oncol. 2020 Jan;25(1):1-42. doi: 10.1007/s10147-019-01485-z. Epub 2019 Jun 15.
3
Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.T1 结直肠肿瘤淋巴结转移的病理危险因素和预测性内镜因素:一项 846 例病变的单中心研究。
J Gastroenterol. 2019 Aug;54(8):708-717. doi: 10.1007/s00535-019-01564-y. Epub 2019 Feb 27.
4
Surgical or endoscopic management of malignant colon polyps.恶性结肠息肉的手术或内镜治疗。
ANZ J Surg. 2018 Dec;88(12):E824-E828. doi: 10.1111/ans.14846. Epub 2018 Oct 22.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
A novel ability of endocytoscopy to diagnose histological grade of differentiation in T1 colorectal carcinomas.内视镜下活检术诊断 T1 期结直肠癌组织学分级的新能力。
Endoscopy. 2018 Jan;50(1):69-74. doi: 10.1055/s-0043-117403. Epub 2017 Sep 29.
7
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2016年结直肠癌治疗指南。
Int J Clin Oncol. 2018 Feb;23(1):1-34. doi: 10.1007/s10147-017-1101-6. Epub 2017 Mar 27.
8
Management of T1 colorectal cancers after endoscopic treatment based on the risk stratification of lymph node metastasis.基于淋巴结转移风险分层的内镜治疗后T1期结直肠癌的管理
J Gastroenterol Hepatol. 2016 Jun;31(6):1126-32. doi: 10.1111/jgh.13257.
9
Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma.早期结直肠癌患者淋巴结转移预测性临床病理因素的Meta分析。
J Korean Med Sci. 2015 Apr;30(4):398-406. doi: 10.3346/jkms.2015.30.4.398. Epub 2015 Mar 19.
10
Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer.系统评价和荟萃分析 T1 结直肠癌淋巴结转移的组织病理学预测因素。
J Gastroenterol. 2015 Jul;50(7):727-34. doi: 10.1007/s00535-015-1057-0. Epub 2015 Mar 1.